Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Thread Morons -- Ignore unavailable to you. Want to Upgrade?

To: Diver who wrote (1231)	6/5/1998 10:33:00 AM
From: X Y Zebra	Read Replies (1) \| Respond to of 12810

I think you may have over-researched the subject <LOL> Yes, I know.... but, sometimes one finds fun things, besides..... Nihil est--in vita priore ego imperator Romanus fui. Z.

To: Diver who wrote (1231)	6/5/1998 11:46:00 AM
From: X Y Zebra	Respond to of 12810

I think you may have over-researched the subject <LOL> Sorry to respond again to this subject matter, already addressed, however, in doing serious research on other issues, I came across the following: First "where" I came across this jewel: #reply-4706506 and the subject matter I found: biz.yahoo.com As follows: (Bold emphasis mine) ----------------------------------------copy begins------------ Wednesday June 3, 2:04 pm Eastern Time RESEARCH ALERT - Vivus cut to hold NEW YORK, June 3 (Reuters) - Genesis Merchant Group Securities said its analyst Chris Tihansky lowered his rating on Vivus Inc. to hold from long-term buy. -- Following the release of several studies on its MUSE impotence product, the analyst said in a news release that it appears Muse ''will be relegated to a niche product in doctors' armament for treating patients with erectile dysfunction.'' -- Additionally, there does not appear to be overwhelming support among urologists for using MUSE as the preferred form of treatment, Tihansky said. -- Data presented at the American Urological Association meeting on Tuesday showed efficacy rates ranging from 10 percent to 58 percent, and penile pain ranging from 20 percent to 40 percent, the analyst said. -- These results differ significantly from those published previously in the New England Journal of Medicine, he said. ------------------------------end copy--------------------- Now, with an entire society completely mesmerized by "erectile dysfunction", "penile pain", and "Presidential Boinking", perhaps over-researching "penise subject matters", may be after all, not entirely out of line....... At least I am having fun.....doing the research that is, and posting my findings..... where else, but at the "Thread Morons".... I agree with the following: "The older I grow the more I distrust the familiar doctrine that age brings wisdom." Z.